Report Overview
The market for digital pathology worldwide, which was worth USD 0.9 billion in 2022, is anticipated to increase rapidly over the next few years, reaching up to USD 1.7 billion by 2030. During the projected period (2023-2030), the global market for digital pathology is anticipated to grow at a CAGR of 8.7%.
The digitalization of glass slides, the creation of software for image processing and storage, and the incorporation of these technologies into the pathology workflow are all included in the digital pathology market. Digital pathology is revolutionising this process by enabling the digitalization of slides and the remote viewing and analysis of pictures. Traditionally, pathologists have relied on glass slides and microscopes to analyse tissue samples for diagnosis. The benefits of this digitalization include increased productivity, teamwork, and pathological data accessibility.
The rising prevalence of chronic diseases, the incorporation of artificial intelligence (AI), the growing adoption of digital pathology to improve lab efficiency, technological advancements in digital pathology systems, the rising geriatric population, and the growing applications of digital pathology in companion diagnostics and drug development are some of the factors driving the global market for digital pathology.
For More Insights request free Sample: https://www.datamintelligence.com/download-sample/digital-pathology-market
Market Dynamics
The Digital Pathology Market is Expanding Due to Growing Adoption of Digital Pathology to Boost Lab Efficiency
The market for digital pathology has been expanding due to the gradually rising acceptance of this technology in recent years. A computer or other digital device can store, manage, and analyse pathology images thanks to digital pathology, which entails digitising glass slides.
The popularity of digital pathology is growing, which has the potential to increase laboratory productivity. The use of actual glass slides in traditional pathology procedures necessitates manual handling, storage, and transportation. This procedure can take a long time and be error-prone. Since there is no longer a need for actual slides and pathologists may access and analyse images remotely thanks to digital pathology, workflow efficiency is increased and diagnosis turnaround times are sped up.
For instance, the new NanoZoomer S20MD Slide scanner system will be released in March 2023, according to Hamamatsu Photonics, a world leader in imaging technology. This innovative new tool was created to give clinical pathologists more workspace flexibility in the lab.
The market for companion diagnostics and drug development is expanding because to increasing applications in these fields.
Companion diagnostics is the use of diagnostic tests to determine which patients may most likely benefit from a certain therapeutic intervention. By enabling the study of tissue samples and biomarkers to ascertain a patient's eligibility for targeted therapy, digital pathology plays a significant part in companion diagnostics.
For instance, the pharmaceutical and diagnostics business Roche said in February 2023 that it had strengthened its research and innovation efforts by expanding its partnership with Janssen Biotech Inc. to develop companion diagnostics for targeted medicines.
The market will experience slower market growth because to the high cost of digital pathology systems.
The high price of digital pathology systems may hinder the market's expansion. Infrastructure for digital pathology, such as slide scanners, image processing software, storage systems, and communication platforms, can require a sizable initial investment. The overall cost may also increase as a result of continuing maintenance and software upgrades.
View Full Report: https://www.datamintelligence.com/research-report/digital-pathology-market
Digital Pathology Market Companies
Key players are F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., Olympus Corporation, Leica Biosystems Nussloch GmbH (Danaher Corporation), Hamamatsu Photonics, Inc., Mikroscan Technologies, Inc., Inspirata, Inc. (Fujifilm), Visiopharm A/S, Huron Technologies International Inc., and ContextVision AB.
Related Reports:
Sign in to leave a comment.